Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kazia Therapeutics (KZIA) Interest Expenses (2009 - 2011)

Kazia Therapeutics (KZIA) posted Interest Expenses of -$18198.9 for Q4 2011, down 15.17% on a QoQ basis from -$15801.7 in Q4 2010, and down 15.17% year-over-year from -$21453.5 in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of Interest Expenses data on file, last reported at -$18198.9 in Q4 2011.

  • In Q4 2011, Interest Expenses fell 15.17% year-over-year to -$18198.9; the TTM figure through Dec 2016 stood at -$18198.9 (changed N/A YoY), while the FY2011 annual figure was -$17798.8, down 34.49% from the prior year.
  • Interest Expenses retreated to -$18198.9 in Q4 2011, from -$15801.7 in the prior quarter.
  • Across five years, Interest Expenses topped out at -$9998.5 in Q4 2009 and bottomed at -$18198.9 in Q4 2011.
  • A 3-year average of -$14666.4 and a median of -$15801.7 in 2010 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2010 — Interest Expenses slumped 58.04% — and 2011, when it dropped 15.17%.
  • Year by year, Interest Expenses stood at -$9998.5 in 2009, then slumped by 58.04% to -$15801.7 in 2010, then slipped by 15.17% to -$18198.9 in 2011.
  • The last three Interest Expenses figures came in at -$18198.9 (Q4 2011), -$15801.7 (Q4 2010), and -$9998.5 (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 22,854.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -5.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 61,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -332,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 69.29 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -18,198.90
Dec 31, 2011 -18,198.90
Dec 31, 2010 -15,801.72
Dec 31, 2010 -15,801.72
Dec 31, 2009 -9,998.47
Dec 31, 2009 -9,998.47